PARAMETRIC PORTFOLIO ASSOCIATES LLC - RECRO PHARMA INC ownership

RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 76 filers reported holding RECRO PHARMA INC in Q1 2021. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.

Quarter-by-quarter ownership
PARAMETRIC PORTFOLIO ASSOCIATES LLC ownership history of RECRO PHARMA INC
ValueSharesWeighting
Q3 2021$36,000
-52.0%
17,473
-45.9%
0.00%
Q2 2021$75,000
-55.4%
32,318
-46.3%
0.00%
Q1 2021$168,000
-3.4%
60,218
-1.3%
0.00%
Q4 2020$174,000
+67.3%
60,995
+23.4%
0.00%
Q3 2020$104,000
-36.2%
49,435
+37.7%
0.00%
Q2 2020$163,000
-70.3%
35,892
-46.5%
0.00%
-100.0%
Q1 2020$548,000
-78.8%
67,133
-52.4%
0.00%
-50.0%
Q4 2019$2,585,000
+118.1%
141,045
+31.9%
0.00%
+100.0%
Q3 2019$1,185,000
+9.4%
106,909
+0.4%
0.00%0.0%
Q2 2019$1,083,000
+109.9%
106,533
+21.1%
0.00%
Q1 2019$516,000
-15.8%
87,989
+1.9%
0.00%
-100.0%
Q4 2018$613,000
+0.2%
86,382
+0.3%
0.00%0.0%
Q3 2018$612,000
+230.8%
86,095
+134.2%
0.00%
Q2 2018$185,000
-16.3%
36,760
+83.3%
0.00%
Q1 2018$221,000
+40.8%
20,055
+18.2%
0.00%
Q4 2017$157,000
+6.1%
16,968
+3.3%
0.00%
Q3 2017$148,00016,4280.00%
Other shareholders
RECRO PHARMA INC shareholders Q1 2021
NameSharesValueWeighting ↓
Athyrium Capital Management, LP 2,202,420$6,145,0003.11%
Samjo Capital LLC 560,000$1,562,0001.16%
MAK CAPITAL ONE LLC 1,224,264$3,416,0000.81%
Cowen Prime Services LLC 470,500$1,313,0000.50%
Portolan Capital Management 1,957,283$5,461,0000.43%
Parkman Healthcare Partners LLC 601,967$1,679,0000.39%
Rubric Capital Management LP 1,076,587$3,004,0000.18%
Frontier Wealth Management LLC 49,112$2,142,0000.16%
ESSEX INVESTMENT MANAGEMENT CO LLC 466,992$1,303,0000.16%
AWM Investment Company, Inc. 391,304$1,092,0000.12%
View complete list of RECRO PHARMA INC shareholders